Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure (Q33870232)

29 July 2017

1 reference

title

Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure (English)

1 reference

29 July 2017

1 reference

Riordan SM

1

1 reference

29 July 2017

Williams R

series ordinal

2

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

published in

Journal of Hepatology

1 reference

29 July 2017

volume

32

1 reference

29 July 2017

issue

1 Suppl

1 reference

29 July 2017

page(s)

63-76

1 reference

Household bleach as disinfectant for use by injecting drug users

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Liver cell necrosis: cellular mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Impaired liver regeneration in inducible nitric oxide synthasedeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Tolerance against tumor necrosis factor alpha (TNF)-induced hepatotoxicity in mice: the role of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Early events in the regulation of hepatocyte DNA synthesis: the role of alpha-adrenergic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Signal transduction during liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Acute phase responses after acute liver injury by partial hepatectomy in rats as indicators of cytokine release

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Evidence for liver cell proliferation during fatal acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Continuous HGF supply from HGF-expressing fibroblasts transplanted into spleen prevents CCl4-induced acute liver injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

The beneficial effects of ciprofloxacin on survival and hepatic regenerative activity in a rat model of fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Contrasting effects of identical nutrients given parenterally or enterally after 70% hepatectomy: Bacterial translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Fungal infection: a common, unrecognised complication of acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Cardiovascular, pulmonary and renal complications of fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Tissue hypoxia during fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

A comparison between the Fick method and indirect calorimetry for determining oxygen consumption in patients with fulminant hepatic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Ammonia: key factor in the pathogenesis of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

False neurotransmitters and hepatic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Concentrations of 3,4‐Dihydroxyphenylalanine and Catecholamines and Metabolites in Brain in an Anhepatic Model of Hepatic Encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Metabolic abnormalities and grade of encephalopathy in acute hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Evidence for altered central noradrenergic function in experimental acute liver failure in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

"Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Liver function, cerebral blood flow autoregulation, and hepatic encephalopathy in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Defective cerebrovascular autoregulation after carotid endarterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Controlled trial of exchange-transfusion therapy in fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Effects of haemoperfusion through charcoal or XAD-2 resin on an animal model of fulminant liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Clinical experience with charcoal and resin hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Charcoal haemoperfusion in the treatment of fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Earlier charcoal haemoperfusion in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Effects of serial resin hemoperfusion in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Removing substances from blood by affinity chromatography. I. Removing bilirubin and other albumin-bound substances from plasma and blood with albumin-conjugated agarose beads

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Cell-matrix interactions in liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Alteration of transcription factor mRNAs during the isolation and culture of rat hepatocytes suggests the activation of a proliferative mode underlies their de-differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Hepatocyte cell lines established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Hepatocarcinogenesis in Transgenic Mice Carrying Albumin-promoted SV40 T Antigen Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Establishment of a human hepatocyte line derived from primary culture in a collagen gel sandwich culture system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Characterization of human hepatocyte lines derived from normal liver tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Infection of human cells by an endogenous retrovirus of pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Influence of alginate gel entrapment and cryopreservation on survival and xenobiotic metabolism capacity of rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Cryopreservation of porcine hepatocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Optimization of hepatocyte attachment to microcarriers: Importance of oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

The Hepatix extracorporeal liver assist device: initial clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Hepatocyte culture between three dimensionally arranged biomatrix-coated independent artificial capillary systems and sinusoidal endothelial cell co-culture compartments

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

A novel bioreactor design for in vitro reconstruction of in vivo liver characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Development of a bioartificial liver with sandwiched-cultured hepatocytes between two collagen gel layers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Use of bioartificial and artificial liver support devices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Loss and recovery of liver regeneration in rats with fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

A functional model of hepatocyte transplantation for in vivo immunologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

Principles of therapeutic liver repopulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980416-X

7 January 2021

10.1016/S0168-8278(00)80416-X

Identifiers

DOI

1 reference

29 July 2017

1 reference